SyncAblate gives the clinician live guidance toward a respiratory-moving target, and confirms the moment is right before each move — with the clinician always in control.
Liver & lung · biopsy and ablation · the clinician stays in control
In CT-guided liver and lung procedures, the clinician steers a needle toward a target that moves with every breath — judging direction and timing by eye and experience alone.
A liver or lung target can travel well over a centimetre with normal breathing — and substantially more under deeper breaths. A few millimetres is the difference between a clean sample and a missed one.
A CT scan captures a single instant. Between scans, exactly where the target sits at any given moment has to be judged — and repeated scanning adds both time and radiation.
Whether the needle is on-line, and whether this is the moment to advance, are judged in real time by eye. The aligned window can last a fraction of a second.
SyncAblate adds one missing layer: clear, real-time guidance toward the target, confirmed safe before each move. It does not replace the clinician, the CT, or the ultrasound, and it never moves the needle. If demonstrated in physical testing, continuous guidance could help clinicians maintain alignment with a respiratory-moving target between imaging updates — while keeping the clinician in control.
The system works from the target's motion in real time, not from a static snapshot taken at the start.
It anticipates the target's motion a fraction ahead, so the guidance stays ahead of it rather than chasing it.
It turns that into clear, real-time guidance for the clinician, and confirms alignment is right before each move. Guidance is the heart of it; safety is built in.
SyncAblate doesn't replace the clinician's hands — it guides them. Live guidance to a moving target, confirmed at the moment alignment is right.
SyncAblate has been selected as a semi-finalist in the 2026 Australian Technologies Competition, in the MedTech & Pharma — Biotech, Device & Other category, from a field of more than 200 applications.
The core guidance concept has been demonstrated in computational simulation against published respiratory-motion data. The next milestone is a physical bench prototype.
Every figure below comes from computational simulation against published respiratory-motion data. The next step is a physical bench prototype.
Pre-prototype. Demonstrated in computational simulation. No patient data. SyncAblate has not been built as a physical device and has not been used in any clinical procedure. All performance characteristics are derived from simulation and establish mathematical feasibility only — they are not clinical claims.
An honest map from concept to clinic — and exactly how far along the project is right now.
Clinical perspective on the workflow and the value of real-time guidance at the point of commitment.
A guidance-and-safety layer designed to integrate with existing needle and ablation platforms.
Selective collaboration on the path from simulation toward physical evidence.
An IP-protected concept at an early, clearly defined stage.
Detailed materials are shared under a confidentiality agreement. If you're a clinician, manufacturer, research partner, or investor, get in touch to start the conversation.
Contact Frank Mirabito →